MannKind | MNKD - Interest Income


MannKind reported $1.43M in Interest Income for its fiscal quarter ending in March of 2026.





Interest Income Change Date
Adma Biologics USD 1.09M 717K Mar/2026
BioCryst Pharmaceuticals USD -0.13 3.59M Dec/2024
Eli Lilly USD 65M 25M Sep/2025
Insmed USD 765K 55K Sep/2024
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
MacroGenics USD 1.55M 26K Mar/2026
MannKind USD 1.43M 208K Mar/2026
Merck USD 35M 34M Mar/2026
Novavax USD 303K 27K Dec/2021
Novo Nordisk DKK 6.05B 2.63B Mar/2026
Pfizer USD -0.04 115M Jun/2026
Sanofi EUR 77M 17M Jun/2026
Xencor USD 5.46M 741K Mar/2026